DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DMP - DE000A2GS5D8 - Common Stock
38.05 EUR
+0.05 (+0.13%)
Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 55 industry peers in the Pharmaceuticals industry. DMP has an average financial health and profitability rating. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
In the past year DMP had a positive cash flow from operations.
In the past 5 years DMP has always been profitable.
Each year in the past 5 years DMP had a positive operating cash flow.
1.2 Ratios
DMP has a Return On Assets (5.48%) which is in line with its industry peers.
DMP has a Return On Equity of 17.87%. This is comparable to the rest of the industry: DMP outperforms 60.00% of its industry peers.
DMP has a Return On Invested Capital (7.26%) which is in line with its industry peers.
DMP had an Average Return On Invested Capital over the past 3 years of 9.78%. This is below the industry average of 13.92%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROIC | 7.26% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP has a Profit Margin (10.00%) which is in line with its industry peers.
DMP's Profit Margin has declined in the last couple of years.
The Operating Margin of DMP (18.70%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DMP has grown nicely.
DMP has a worse Gross Margin (66.57%) than 61.82% of its industry peers.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
DMP has about the same amout of shares outstanding than it did 5 years ago.
DMP has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.25 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
DMP has a Altman-Z score of 2.25. This is comparable to the rest of the industry: DMP outperforms 47.27% of its industry peers.
DMP has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as DMP would need 6.15 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.15, DMP perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
DMP has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of DMP (1.44) is worse than 74.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 2.25 |
ROIC/WACC1.16
WACC6.28%
2.3 Liquidity
A Current Ratio of 2.20 indicates that DMP has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.20, DMP is doing good in the industry, outperforming 74.55% of the companies in the same industry.
A Quick Ratio of 1.04 indicates that DMP should not have too much problems paying its short term obligations.
The Quick ratio of DMP (1.04) is better than 61.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.01% over the past year.
The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
The Revenue has been growing slightly by 0.11% in the past year.
Measured over the past years, DMP shows a quite strong growth in Revenue. The Revenue has been growing by 11.00% on average per year.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
3.2 Future
The Earnings Per Share is expected to grow by 14.68% on average over the next years. This is quite good.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 3.09% on average per year.
EPS Next Y13%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
EPS Next 5Y14.68%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y3.09%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.70 indicates a rather expensive valuation of DMP.
Based on the Price/Earnings ratio, DMP is valued a bit cheaper than 61.82% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.46. DMP is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 14.84 indicates a correct valuation of DMP.
DMP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DMP is cheaper than 63.64% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.10. DMP is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.7 | ||
| Fwd PE | 14.84 |
4.2 Price Multiples
72.73% of the companies in the same industry are more expensive than DMP, based on the Enterprise Value to EBITDA ratio.
DMP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DMP is cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.46 | ||
| EV/EBITDA | 9.62 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.36
PEG (5Y)2.19
EPS Next 2Y11.96%
EPS Next 3Y11.07%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.41%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.86, DMP pays a bit more dividend than its industry peers.
DMP's Dividend Yield is comparable with the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.41% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.76%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
FRA:DMP (12/5/2025, 5:29:50 PM)
38.05
+0.05 (+0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners12.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.05B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (12.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.41% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.94%
PT rev (3m)-7.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.7 | ||
| Fwd PE | 14.84 | ||
| P/S | 1.77 | ||
| P/FCF | 12.46 | ||
| P/OCF | 9.92 | ||
| P/B | 3.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.62 |
EPS(TTM)2.15
EY5.65%
EPS(NY)2.56
Fwd EY6.74%
FCF(TTM)3.05
FCFY8.03%
OCF(TTM)3.84
OCFY10.08%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.36
PEG (5Y)2.19
Graham Number24.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROCE | 11.89% | ||
| ROIC | 7.26% | ||
| ROICexc | 7.91% | ||
| ROICexgc | 21.74% | ||
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% | ||
| FCFM | 14.17% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | 3.09 | ||
| Cap/Depr | 49.31% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 4.01 | ||
| Cash Conversion | 68.3% | ||
| Profit Quality | 141.71% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 2.25 |
F-Score7
WACC6.28%
ROIC/WACC1.16
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y13%
EPS Next 2Y11.96%
EPS Next 3Y11.07%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.58%
Revenue Next 2Y1.65%
Revenue Next 3Y2.36%
Revenue Next 5Y3.09%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.14%
EBIT Next 3Y20.11%
EBIT Next 5Y7.73%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
What is the valuation status for DMP stock?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for DMP stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.7 and the Price/Book (PB) ratio is 3.16.
What is the earnings growth outlook for DERMAPHARM HOLDING SE?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 13% in the next year.